GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dar Al Dawa Development and Investment (AMM:DADI) » Definitions » Days Sales Outstanding

Dar Al Dawa Development and Investment (AMM:DADI) Days Sales Outstanding : 150.33 (As of Mar. 2024)


View and export this data going back to 1978. Start your Free Trial

What is Dar Al Dawa Development and Investment Days Sales Outstanding?

Dar Al Dawa Development and Investment's average Accounts Receivable for the three months ended in Mar. 2024 was JOD22.45 Mil. Dar Al Dawa Development and Investment's Revenue for the three months ended in Mar. 2024 was JOD13.63 Mil. Hence, Dar Al Dawa Development and Investment's Days Sales Outstanding for the three months ended in Mar. 2024 was 150.33.

The historical rank and industry rank for Dar Al Dawa Development and Investment's Days Sales Outstanding or its related term are showing as below:

AMM:DADI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 91.71   Med: 132.81   Max: 251.18
Current: 149.42

During the past 13 years, Dar Al Dawa Development and Investment's highest Days Sales Outstanding was 251.18. The lowest was 91.71. And the median was 132.81.

AMM:DADI's Days Sales Outstanding is ranked worse than
89.87% of 997 companies
in the Drug Manufacturers industry
Industry Median: 71.44 vs AMM:DADI: 149.42

Dar Al Dawa Development and Investment's Days Sales Outstanding declined from Mar. 2023 (211.55) to Mar. 2024 (150.33).


Dar Al Dawa Development and Investment Days Sales Outstanding Historical Data

The historical data trend for Dar Al Dawa Development and Investment's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dar Al Dawa Development and Investment Days Sales Outstanding Chart

Dar Al Dawa Development and Investment Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 189.38 116.12 116.68 110.30 91.71

Dar Al Dawa Development and Investment Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 211.55 172.84 143.60 121.42 150.33

Competitive Comparison of Dar Al Dawa Development and Investment's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Dar Al Dawa Development and Investment's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dar Al Dawa Development and Investment's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dar Al Dawa Development and Investment's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Dar Al Dawa Development and Investment's Days Sales Outstanding falls into.



Dar Al Dawa Development and Investment Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Dar Al Dawa Development and Investment's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (19.322 + 18.307) / 2 ) / 74.879*365
=18.8145 / 74.879*365
=91.71

Dar Al Dawa Development and Investment's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (18.307 + 26.588) / 2 ) / 13.626*365 / 4
=22.4475 / 13.626*365 / 4
=150.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dar Al Dawa Development and Investment  (AMM:DADI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Dar Al Dawa Development and Investment Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Dar Al Dawa Development and Investment's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Dar Al Dawa Development and Investment (AMM:DADI) Business Description

Traded in Other Exchanges
N/A
Address
Naour, P.O. Box 9364, Amman, JOR, 11191
Dar Al Dawa Development and Investment is a pharmaceutical company. The main objectives of the company are to manufacture pharmaceutical, chemical, pharmaceutical, and related products and to import medicines. It offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, dermatology, eye-ear preparations, gastroenterology and metabolism, genitourinary system and sex hormones, musculoskeletal system, nervous system, ophthalmological/otological, and respiratory system, as well as vitamins. The company's geographical segments are Levant and Iraq, Gulf and Yemen, Africa, and Europe and Asia.

Dar Al Dawa Development and Investment (AMM:DADI) Headlines

No Headlines